Alzheon is committed to developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders.

Biotechnology

Alzheon

Alzheon's headquarters in Framingham, MA, United States

Martin Tolar

Adem Albayrak

Stacey Kaufusi

Yasemin Khakian

Earvin Liang

Kenneth Mace

Aidan Power

Susan Abushakra

John Hey

Diane K. Jorkasky

Jordan Heller

Christopher Noel Dunn

Neil Flanzraich

Kaj Blennow

Jakub Hort

Serge Gauthier

Steven Jacobsen

Louis Kirby

Miia Kivipelto

William Mobley

Anton Porsteinsson

John Sampalis

Eric Reiman

Pete Snyder

Bruno Vellas

Keith Crutcher

Cyril Höschl

Marwan N. Sabbagh

Katerina Sheardova

Carmela R. Abraham

Murali Doraiswamy

Ara S. Khachaturian

Michael W. Weiner

Carl Sadowsky

The Scientific Advisory Team at Alzheon consists of a group of leading experts who provide strategic guidance and expertise on the scientific research and development of innovative medicines targeting neurodegenerative disorders. They play a critical role in aligning the company’s efforts with the latest advancements in scientific knowledge and clinical practices.

Scientific Advisory Team

The Clinical Team at Alzheon is responsible for designing, overseeing, and managing all clinical trials and research studies to ensure the development of effective, safe, and innovative treatments for neurodegenerative disorders. This includes strategic planning, regulatory compliance, and collaboration with medical and operational experts to facilitate successful trial outcomes.

Clinical Team

The Finance Team at Alzheon, comprised of the Chief Financial Officer, VP of Finance, and Finance Manager, is responsible for managing the company’s financial health. They oversee budgeting, forecasting, financial planning, and analysis to ensure funding and resources are optimally allocated towards the development of innovative medicines for neurodegenerative disorders.

Finance Team

This department provides oversight and guidance for the organization's strategic direction and decision-making processes.

Governance Committee

This department focuses on developing and overseeing AI technologies and applications.

Artificial Intelligence

This department oversees strategic planning and executive decision-making within the organization.

Executive Leadership

Alzheon

Org chart

Board & advisors

Teams

Scientific Advisory Team

Clinical Team

Finance Team

Governance Committee

Artificial Intelligence

Executive Leadership

Offices

Alzheon

Org chart

Board & advisors

Teams

Scientific Advisory Team

Clinical Team

Finance Team

Governance Committee

Artificial Intelligence

Executive Leadership

Offices

Related companies